Ascent Group’s Sanofi SNY Stock Holding History

Ascent Group’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-7,279	Closed	-$352K	–	786
2025 Q2	$352K	Sell	7,279 -401	-5%	-$20.5K	0.01%	541
2025 Q1	$426K	Buy	+7,680	New	+$416K	0.02%	493
2022 Q1	–	Sell	-6,820	Closed	-$349K	–	462
2021 Q4	$349K	Buy	+6,820	New	+$337K	0.04%	355

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Ascent Group's SNY Position: Q3 2025 in Review

Ascent Group sold out of Sanofi (SNY) in Q3 2025, closing a stake of 7,279 shares — an estimated $352K sold.

Ascent Group first reported a position in SNY in Q4 2021 and held it in 3 quarters. The position peaked at $426K in Q1 2025. 712 funds tracked by Wall St. Rank hold SNY as of Q3 2025.

Ascent Group reported no remaining Sanofi position as of Q3 2025 after selling out during the quarter.
Ascent Group sold 7,279 Sanofi shares in Q3 2025, an estimated $352K.
Ascent Group first reported a position in Sanofi in Q4 2021 and held it in 3 quarters.
Ascent Group's Sanofi position peaked at $426K in Q1 2025.
712 funds tracked by Wall St. Rank held Sanofi as of Q3 2025.

Based on Ascent Group's 13F filing for Q3 2025, filed 20 Oct 2025.